We are committed to finding a safe, effective, and patient-friendly therapy for food and pediatric allergy patients

 

OLFUS-VIPES Results

Latest News

DBV Technologies Reports December 31, 2016 Cash Position

DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT®

Documentation

20-F Form 2015

Agenda

Barclays Global Healthcare Conference

Miami, USA

EAACI Congress 2016

The EAACI (European Academy Allergy and Clinical Immunology) Congress took place in Vienna from June 11th to 15th.

Epicutaneous Immunotherapy